Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2019 · 10-Q
Revenue$2.93M$2.93M+62.0% vs Q3 2018 Net Income-$1.12M-$1.12MN/M vs Q3 2018 EPS Diluted-$0.08-$0.08N/M vs Q3 2018 Operating Income-$910,529N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-31.1%+35.6 pt vs Q3 2018
Net margin-38.4%+40.7 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 13, 2019 · 44 d after period end